1 |
highly active antiretroviral therapy
(8719 times)
|
Acquired Immunodeficiency Syndrome (2087 times)
|
HIV (1852 times) CI (505 times) AIDS (436 times)
|
1997 Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.
|
2 |
highly active ART
(24 times)
|
Medicine (5 times)
|
ART (22 times) HIV (8 times) TB (3 times)
|
2001 Effects of drug abuse and mental disorders on use and type of antiretroviral therapy in HIV-infected persons.
|
3 |
highly active ARV therapy
(5 times)
|
Medicine (2 times)
|
ARV (2 times) ARVs (2 times) HIV (2 times)
|
2005 Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
|
4 |
HIV patients receiving antiretroviral therapy
(4 times)
|
Dentistry (2 times)
|
CAL (1 time) CI (1 time) HP (1 time)
|
2006 Symptom exacerbation and adherence to antiretroviral therapy during the menstrual cycle: a pilot study.
|
5 |
cocktails-high active anti-retroviral therapy
(2 times)
|
Drug Therapy (2 times)
|
AIDS (2 times) HIV (1 time)
|
2015 New Perspectives of HIV/AIDS Therapy Study.
|
6 |
HIV infection and long-term antiretroviral therapy
(2 times)
|
Communicable Diseases (1 time)
|
MFI (1 time)
|
2004 [CD38 antigen as a marker for immunological follow-up in HIV-positive patients].
|
7 |
HIV/AIDS on anti-retroviral therapy
(2 times)
|
Dermatology (1 time)
|
ACLD (1 time) TMP-SMX (1 time)
|
2011 Photolichenoid plaques with associated vitiliginous pigmentary changes.
|
8 |
anti-HIV therapy
(1 time)
|
Internal Medicine (1 time)
|
---
|
2009 [Practice of anti-HIV therapy (HAART)].
|
9 |
anything about antiretroviral treatment
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
ARVs (1 time) MTCT (1 time) TB (1 time)
|
2005 Knowledge and acceptability of HAART among TB patients in Durban, South Africa.
|
10 |
H. pylori, fungal colonization, and antiretroviral treatment
(1 time)
|
Medicine (1 time)
|
GI (1 time)
|
2006 Morphological changes of the upper gastrointestinal tract mucosa and Helicobacter pylori infection in HIV-positive patients with severe immunodeficiency and symptoms of dyspepsia.
|
11 |
HAART cohort
(1 time)
|
Medicine (1 time)
|
CI (1 time) DM (1 time) HCV (1 time)
|
2018 Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study.
|
12 |
HAART group
(1 time)
|
Anti-Bacterial Agents (1 time)
|
SILs (1 time)
|
2007 Highly active antiretroviral therapy and incidence of cervical squamous intraepithelial lesions among HIV-infected women with normal cytology and CD4 counts above 350 cells/mm3.
|
13 |
HAART responders
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
FGF-2 (1 time) TNF-alpha (1 time)
|
2011 The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of women.
|
14 |
HAART use group
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
HR (2 times) CI (1 time) HZ (1 time)
|
2014 Effects of highly active antiretroviral therapy and its adherence on herpes zoster incidence: a longitudinal cohort study.
|
15 |
has been reported that antiretroviral therapy
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
IFN-gamma (1 time) IL-2 (1 time)
|
2005 Analysis of the effect of highly active antiretroviral therapy during acute HIV-1 infection on HIV-specific CD4 T cell functions.
|
16 |
has changed after the introduction of new potent antiretroviral therapies
(1 time)
|
Medicine (1 time)
|
---
|
2000 [The efficacy of antiretroviral treatment in patients with human immunodeficiency virus infection. A study of 807 patients].
|
17 |
has declined considerably with the introduction of tritherapy
(1 time)
|
Pulmonary Medicine (1 time)
|
---
|
2007 [Lung cancer in HIV-positive patients].
|
18 |
has not shown a benefit in patients on tri-therapy
(1 time)
|
Communicable Diseases (1 time)
|
ART (2 times) HIV (1 time)
|
2005 [Human immunodeficiency virus (HIV) infection in pregnancy: antiretroviral treatment (ART) and mode of delivery].
|
19 |
has profound negative effect on the optic nerve even though
(1 time)
|
Medicine (1 time)
|
HIV (1 time) ONSD (1 time) SD (1 time)
|
2019 Transorbital sonographic measurement of optic nerve sheath diameter among HIV-Positive patients in Northwestern Nigeria.
|
20 |
have been achieved since the introduction of the combination therapy
(1 time)
|
Chemistry (1 time)
|
---
|
2015 Improving bioavailability and biodistribution of anti-HIV chemotherapy.
|
21 |
have been associated with the medication regimen
(1 time)
|
General Surgery (1 time)
|
---
|
2006 HIV and hyperlipidemia: current recommendations and treatment.
|
22 |
have explored socioeconomic status, access to triple therapy
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
RR (1 time)
|
2002 Socioeconomic status, access to triple therapy, and survival from HIV-disease since 1996.
|
23 |
hemerocallidea extract and antiretroviral therapy
(1 time)
|
Reproductive Medicine (1 time)
|
HH (1 time)
|
2016 Effect of co-administration of Hypoxis hemerocallidea extract and antiretroviral therapy (HAART) on the histomorphology and seminal parameters in Sprague Dawley rats.
|
24 |
hemispherical aortic annuloplasty reconstructive technology
(1 time)
|
Cardiology (1 time)
|
---
|
2022 Four-dimensional magnetic resonance after ascending aorta replacement and aortic valve repair with HAART 300 internal annuloplasty ring.
|
25 |
hepatitis B and C seropositivity in treatment with antiretroviral drugs
(1 time)
|
Endocrine System Diseases (1 time)
|
---
|
2019 Relationship Between Vertebral Fractures, Bone Mineral Density, and Osteometabolic Profile in HIV and Hepatitis B and C-Infected Patients Treated With ART.
|
26 |
high acting anti-retrovirals
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
---
|
2002 Adherence discourse among African-American women taking HAART.
|
27 |
highly promising agents for use as an effective anti-retroviral therapy
(1 time)
|
Computational Biology (1 time)
|
RT (1 time)
|
2021 Molecular docking based design of Inhibitors for viral Non-Nucleosidase as potential anti-retroviral agents.
|
28 |
HIV in patients on optimal long-term antiretroviral therapy
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
---
|
2012 Design and implementation of a randomized crossover study of valproic acid and antiretroviral therapy to reduce the HIV reservoir.
|
29 |
HIV infected females on antiretroviral therapy
(1 time)
|
Medicine (1 time)
|
PROG (1 time)
|
2017 Impact of thyroid function abnormalities on reproductive hormones during menstrual cycle in premenopausal HIV infected females at NAUTH, Nnewi, Nigeria.
|
30 |
HIV infected patients after treatment with combinations of drugs
(1 time)
|
Chemistry (1 time)
|
---
|
2003 Reservoirs of HIV replication after successful combined antiretroviral treatment.
|
31 |
HIV infection and cytomegalovirus retinitis in whom antiretroviral therapy
(1 time)
|
Communicable Diseases (1 time)
|
---
|
2001 Simultaneous occurrence of 2 HIV-related immunereconstitution diseases after initiation of highly active antiretroviral therapy.
|
32 |
HIV infection in spite of successful anti-retroviral therapy
(1 time)
|
Cell Biology (1 time)
|
---
|
2014 Endocannabinoids affect innate immunity of Muller glia during HIV-1 Tat cytotoxicity.
|
33 |
HIV positive patients undergoing treatment with antiretroviral drugs
(1 time)
|
General Surgery (1 time)
|
PLA (1 time)
|
2004 Use of polylactic acid in face lipodystrophy in HIV positive patients undergoing treatment with antiretroviral drugs (HAART).
|
34 |
HIV receive antiretroviral therapy
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
PLHIV (1 time)
|
2016 Model of socio-cultural dimensions involved in adherence to antiretroviral therapy for HIV/AIDS in public health care centers in Chile.
|
35 |
HIV-1 infection, who was asymptomatic without antiretroviral therapy
(1 time)
|
Medicine (1 time)
|
PI (1 time)
|
2005 Severe HIV-1 encephalitis and development of cerebral non-Hodgkin lymphoma in a patient with persistent strong HIV-1 replication in the brain despite potent HAART -- case report and review of the literature.
|
36 |
HIV-1 transmission by antiviral
(1 time)
|
Molecular Biology (1 time)
|
CTLs (1 time) DCs (1 time) ODNs (1 time)
|
2005 CpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.
|
37 |
HIV-combination therapy
(1 time)
|
Substance-Related Disorders (1 time)
|
---
|
2003 Drug users and HIV-combination therapy (HAART): factors which impede or facilitate adherence.
|
38 |
HIV-infected children taking protease inhibitors combined with transcriptase inhibitors
(1 time)
|
Medicine (1 time)
|
---
|
2004 [Cytomegalovirus retinitis in pediatric patients with AIDS receiving highly active antiretrovirus therapy].
|
39 |
HIV-infected men receiving effective antiretroviral therapy
(1 time)
|
Medicine (1 time)
|
---
|
2012 Impact of short-term HAART initiated during the chronic stage or shortly post-exposure on SIV infection of male genital organs.
|
40 |
HIV-infected subjects and decreases after antiretroviral therapy
(1 time)
|
Allergy and Immunology (1 time)
|
sHLA-A,-B,-C (1 time) sHLA-G (1 time)
|
2009 Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
|
41 |
HIV-positive patients receiving antiretroviral treatment
(1 time)
|
Acquired Immunodeficiency Syndrome (1 time)
|
HCV (1 time) IFN-gamma (1 time) qRT-PCR (1 time)
|
2007 Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
|
42 |
HIV/AIDS and its association with adherence to antiretroviral therapy
(1 time)
|
Public Health (1 time)
|
aPR (1 time) CI (1 time) IQR (1 time)
|
2016 [Stigma related to HIV/AIDS associated with adherence to antiretroviral therapy in patients of a public hospital in Lima, Peru 2014].
|
43 |
HIV/AIDS chemotherapy
(1 time)
|
Communicable Diseases (1 time)
|
AIDS (1 time) HIV (1 time)
|
2017 HAART in HIV/AIDS Treatments: Future Trends.
|